Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adjusted survival curve estimation using covariates

R W Makuch

    Journal of Chronic Diseases
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces a method for estimating survival curves with covariates, enhancing Cox

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Evaluation of therapeutic strategies: a new method for balancing risk and benefit.

    Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2006
    Same author

    A stochastic modeling of early HIV-1 population dynamics.

    Mathematical biosciences·2001
    Same author

    Regional brain volume abnormalities and long-term cognitive outcome in preterm infants.

    JAMA·2000
    Same author

    Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.

    The Journal of rheumatology·2000
    Same author

    Outcome of children in the indomethacin intraventricular hemorrhage prevention trial.

    Pediatrics·2000
    Same author

    Blood pressure exceeding national guidelines among women after stroke.

    Stroke·2000
    Same journal

    LEPROMATOUS LEPROSY AND AUSTRALIA ANTIGEN WITH COMMENTS ON THE GENETICS OF LEPROSY.

    Journal of chronic diseases·2015
    Same journal

    HYPERLIPIDEMIA IN AN ADULT DIABETIC POPULATION.

    Journal of chronic diseases·2015
    Same journal

    ESSENTIAL TRACE METALS IN MAN: MOLYBDENUM.

    Journal of chronic diseases·2015
    Same journal

    DISTINGUISHING PHYSIOLOGIC VARIATION FROM ANALYTIC VARIATION.

    Journal of chronic diseases·2015
    Same journal

    THE PRE-THERAPEUTIC CLASSIFICATION OF CO-MORBIDITY IN CHRONIC DISEASE.

    Journal of chronic diseases·2015
    Same journal

    AORTITIS SYNDROME WITH SPECIAL REFERENCE TO ITS CLINICAL PICTURE AND ETIOLOGY.

    Journal of chronic diseases·2015
    See all related articles

    Area of Science:

    • Clinical trials and biostatistics
    • Survival analysis
    • Medical research methodology

    Background:

    • Cox's proportional hazard model is standard for clinical trial survival analysis.
    • Kaplan-Meier curves often appear similar despite statistically significant differences, confusing clinicians.
    • Existing methods like Hankey and Myers' approach offer partial solutions.

    Purpose of the Study:

    • To present a novel method for estimating covariate-adjusted survival curves compatible with Cox's model.
    • To bridge the gap between statistical significance and graphical representation in clinical trial reporting.
    • To improve the interpretability of survival data for medical audiences.

    Main Methods:

    • Developed a method for estimating survival curves incorporating patient covariates within the Cox proportional hazards framework.

    Related Experiment Videos

  • Utilized principles for covariate adjustment in survival data analysis.
  • Applied the method to a clinical trial example for demonstration.
  • Main Results:

    • The proposed method generates graphical displays of survival curves that align with statistical significance levels.
    • Demonstrated improved consistency between statistical findings and visual data representation.
    • The example illustrated the practical utility for medical professionals.

    Conclusions:

    • The described method enhances the visualization of covariate-adjusted survival data in clinical trials.
    • This approach improves the communication of statistically significant survival differences to clinicians.
    • Provides a more intuitive graphical representation of treatment effects in the presence of covariates.